|
Orthologous residues
|
|
LAB (human): Y136‑p, LAB (mouse): Y139‑p, LAB (rat): Y140‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phospho-antibody, western blotting
|
|
Disease tissue studied:
lymphoma, B cell lymphoma
|
|
Relevant cell lines - cell types - tissues:
A20 (B lymphocyte), Jurkat (T lymphocyte), T lymphocyte-thymus
|
|
Cellular systems studied:
cell lines, primary cells
|
|
Species studied:
human, mouse
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
anti-IgG
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Effect of modification (process):
cell differentiation, altered
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
Grb2 (mouse)
|
|
Induces
|
|
|
co-immunoprecipitation
|
|